From: Malaria treatment policy change in Uganda: what role did evidence play?
 |  | High-quality evidence on drug efficacy (CQ/SP and ACTs) | Guidance provided by WHO | Cries from the community | Evidence on cost | Implementation feasibility | Routine monitoring data | Local and international experiences | Observational evidence from clinicians | Evidence on behavioural change |
---|---|---|---|---|---|---|---|---|---|---|
 | Donors | 3 | 3 | 1 | 2 | 1 | 0 | 2 | 1 | 1 |
Public sector | Central level MoH | 7 | 6 | Â | 4 | 1 | 1 | Â | Â | Â |
NMS | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
NDA | 1 | 1 | Â | Â | Â | Â | Â | 1 | Â | |
Service providers | 1 | 2 | 2 | Â | 1 | 1 | Â | Â | Â | |
 | Managers at district level | 2 | 1 |  |  |  | 1 |  |  |  |
 | Researchers | 1 | 1 |  |  |  |  |  |  |  |
Private sector | CSO | 1 | Â | 1 | Â | Â | Â | Â | Â | Â |
Pharmaceutical company | 1 | Â | Â | Â | Â | Â | Â | Â | Â | |
 | Media | 1 |  | 1 |  |  |  | 1 |  |  |
 | Service providers | 1 |  |  |  | 2 |  |  |  |  |
 | Researchers | 1 | 1 | 1 |  | 1 |  |  | 1 |  |
 | Total | 20 | 15 | 6 | 6 | 5 | 3 | 3 | 3 | 1 |